Taken together, our results are in agreement with a recent study in which immunohistochemic staining for the CDKN2A protein in chordoma consistently yielded negative results (Naka et al, 2005), and indicate that inactivation of CDKN2A may be important for chordoma development, although not tumour-type specific. This evidence concerns the gene CDKN2A and neoplasm.